Ertugliflozin and Sitagliptin
Therapeutic Group
Blood Glucose Lowering Drugs, Excluding InsulinIndication Dosage
"Ertugliflozin and Sitagliptin" is indicated for the treatment of type 2 diabetes mellitus. It is prescribed to improve blood sugar control in adults with this condition when diet and exercise alone are not sufficient. Type 2 diabetes is a chronic metabolic disorder characterized by high levels of blood glucose (sugar), and this medication is used to help regulate and lower blood sugar levels in affected individuals.
Dosage:
The typical dosage of "Ertugliflozin and Sitagliptin" is 5 mg of Ertugliflozin and 100 mg of Sitagliptin, both taken once daily. However, dosages may be adjusted based on individual factors, so follow your healthcare provider's instructions.
Content
- Tab 5/100mg, 15/100mg: Ertugliflozin 5/15mg and Sitagliptin 100mg
Pregnancy
Contraindicated in Pregnancy
Stability
- Sodium-Glucose Co- Transporter 2 (SGLT2) Inhibitors
- Dipeptidylpeptidase-4 Inhibitors
Contra Indications
- Severe renal impairment, end-stage renal disease, or dialysis, Pancreatitis, Ketoacidosis
Precautions
- Severe renal impairment, end-stage renal disease, or dialysis, Pancreatitis, Ketoacidosis
Lactation
- Contraindicated or Not Recommended
Side Effects
- Hypoglycemia
- Urinary Tract Infections
- Increased Urination
- Dehydration
- Joint Pain
- Yeast Infections